XML 35 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments (Tables)
6 Months Ended
Sep. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
As of September 30, 2018, the Company had the following derivative contracts recorded at fair value:
 
Designated Derivative Contracts
 
Non-Designated Derivative Contracts
 
Total
Notional value
$
86,015

 
$
38,582

 
$
124,597

Fair value recorded in other current assets
6,722

 
747

 
7,469

Fair value recorded in other accrued expenses

 
(20
)
 
(20
)


Schedule of location and amount of gains and losses related to derivatives designated as hedging instruments reported in consolidated financial statements
The following table summarizes the effect of Designated Derivative Contracts:
 
Three Months Ended September 30,
 
Six Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Amount of gain (loss) on derivative instruments (effective portion) recognized in other comprehensive (loss) income
$
588

 
$
(3,900
)
 
$
7,358

 
$
(9,790
)
Amount of gain (loss) reclassified from accumulated other comprehensive loss into net sales (effective portion)
2,166

 
(2,283
)
 
2,166

 
(2,283
)
Amount of gain excluded from effectiveness testing recognized in SG&A expenses
634

 
439

 
1,480

 
772


Schedule of location and amount of gains and losses related to derivatives not designated as hedging instruments reported in consolidated financial statements
The following table summarizes the effect of Non-Designated Derivative Contracts:
 
Three Months Ended September 30,
 
Six Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Amount of gain (loss) on derivative instruments recognized in SG&A expenses
$
250

 
$
(1,065
)
 
$
737

 
$
(2,668
)